tiprankstipranks
China NT Pharma Group Co., Ltd. (HK:1011)
:1011
Hong Kong Market
1011
China NT Pharma Group Co., Ltd.
RESEARCH TOOLSreports

China NT Pharma Group Co., Ltd. (1011) Ratios

2 Followers

China NT Pharma Group Co., Ltd. Ratios

HK:1011's free cash flow for Q2 2025 was ¥0.83. For the 2025 fiscal year, HK:1011's free cash flow was decreased by ¥ and operating cash flow was ¥>-0.01. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
 0.02 0.02 0.02 0.06 0.30
Quick Ratio
 0.02 0.02 0.02 0.05 0.26
Cash Ratio
 0.01 0.01 <0.01 <0.01 0.01
Solvency Ratio
 -0.04 -0.07 -0.21 -0.04 -0.09
Operating Cash Flow Ratio
 -0.04 -0.01 0.08 0.03 -0.15
Short-Term Operating Cash Flow Coverage
 -0.07 -0.02 0.15 0.04 -0.22
Net Current Asset Value
¥ -606.08M¥ -717.00M¥ -656.41M¥ -1.17B¥ -899.03M
Leverage Ratios
Debt-to-Assets Ratio
 0.91 1.13 1.05 0.82 0.87
Debt-to-Equity Ratio
 -1.16 -0.94 -1.02 -3.42 -3.94
Debt-to-Capital Ratio
 7.35 -16.24 64.15 1.41 1.34
Long-Term Debt-to-Capital Ratio
 0.00 -0.02 >-0.01 0.00 111.38
Financial Leverage Ratio
 -1.27 -0.84 -0.97 -4.16 -4.52
Debt Service Coverage Ratio
 -0.03 -0.02 <0.01 >-0.01 -0.03
Interest Coverage Ratio
 -0.44 -0.42 -1.95 -0.67 -1.12
Debt to Market Cap
 0.75 5.61 0.79 5.47 0.76
Interest Debt Per Share
 0.51 1.54 0.44 0.46 0.49
Net Debt to EBITDA
 -26.17 -42.35 258.21 78.93 -46.28
Profitability Margins
Gross Profit Margin
38.81%13.86%100.00%60.50%64.16%
EBIT Margin
-50.76%-34.84%-61.78%-5.15%-26.48%
EBITDA Margin
-49.39%-22.79%18.06%5.02%-7.84%
Operating Profit Margin
-50.76%-34.84%-763.07%-12.82%-43.86%
Pretax Profit Margin
-108.95%-140.89%-453.01%-24.16%-65.62%
Net Profit Margin
-108.95%-140.56%-1949.36%-32.07%-65.96%
Continuous Operations Profit Margin
-108.95%-140.56%-454.67%-24.16%-66.76%
Net Income Per EBT
100.00%99.77%430.31%132.70%100.53%
EBT Per EBIT
214.64%404.36%59.37%188.53%149.60%
Return on Assets (ROA)
-7.51%-15.97%-43.63%-6.60%-15.65%
Return on Equity (ROE)
9.48%13.37%42.29%27.48%70.75%
Return on Capital Employed (ROCE)
4.44%3.38%16.73%16.19%-167.43%
Return on Invested Capital (ROIC)
-28.35%56.99%-1045.34%-4.01%-14.67%
Return on Tangible Assets
-7.51%-15.97%-43.65%-7.84%-18.82%
Earnings Yield
-6.24%-79.67%-32.78%-44.00%-13.69%
Efficiency Ratios
Receivables Turnover
 7.56 0.00 0.73 6.15 18.21
Payables Turnover
 5.51 65.66 0.00 9.65 1.82
Inventory Turnover
 36.54 194.64 0.00 7.93 2.54
Fixed Asset Turnover
 38.13 69.91 7.80 0.42 0.91
Asset Turnover
 0.07 0.11 0.02 0.21 0.24
Working Capital Turnover Ratio
 -0.04 -0.06 >-0.01 -0.24 -0.38
Cash Conversion Cycle
 -7.99 -3.68 498.10 67.55 -36.67
Days of Sales Outstanding
 48.31 0.00 498.10 59.34 20.05
Days of Inventory Outstanding
 9.99 1.88 0.00 46.04 143.79
Days of Payables Outstanding
 66.29 5.56 0.00 37.82 200.52
Operating Cycle
 58.30 1.88 498.10 105.37 163.84
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.03 -0.03 0.06 0.02 -0.07
Free Cash Flow Per Share
 -0.03 -0.04 0.04 0.02 -0.07
CapEx Per Share
 <0.01 <0.01 0.02 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.02 0.74 0.88 1.00
Dividend Paid and CapEx Coverage Ratio
 -480.02 -50.93 3.91 8.06 -208.63
Capital Expenditure Coverage Ratio
 -480.02 -50.93 3.91 8.06 -208.63
Operating Cash Flow Coverage Ratio
 -0.07 -0.02 0.15 0.04 -0.16
Operating Cash Flow to Sales Ratio
 -0.94 -0.24 6.85 0.17 -0.59
Free Cash Flow Yield
-5.42%-13.80%8.58%21.01%-12.39%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -16.31 -1.26 -3.05 -2.27 -7.31
Price-to-Sales (P/S) Ratio
 17.73 1.76 59.47 0.73 4.82
Price-to-Book (P/B) Ratio
 -1.55 -0.17 -1.29 -0.62 -5.17
Price-to-Free Cash Flow (P/FCF) Ratio
 -18.78 -7.24 11.66 4.76 -8.07
Price-to-Operating Cash Flow Ratio
 -18.86 -7.39 8.68 4.17 -8.11
Price-to-Earnings Growth (PEG) Ratio
 -0.20 -0.07 >-0.01 0.04 0.37
Price-to-Fair Value
 -1.55 -0.17 -1.29 -0.62 -5.17
Enterprise Value Multiple
 -62.06 -50.09 587.56 93.45 -107.75
Enterprise Value
 727.00M 433.30M 781.46M 971.45M 1.92B
EV to EBITDA
 -61.45 -50.09 587.56 93.45 -107.75
EV to Sales
 30.35 11.41 106.09 4.69 8.45
EV to Free Cash Flow
 -32.16 -46.87 20.79 30.63 -14.14
EV to Operating Cash Flow
 -32.22 -47.79 15.48 26.83 -14.21
Tangible Book Value Per Share
 -0.41 -1.51 -0.40 -0.21 -0.20
Shareholders’ Equity Per Share
 -0.41 -1.51 -0.40 -0.13 -0.11
Tax and Other Ratios
Effective Tax Rate
 0.00 <0.01 >-0.01 -0.24 -0.02
Revenue Per Share
 0.04 0.14 <0.01 0.11 0.12
Net Income Per Share
 -0.04 -0.20 -0.17 -0.03 -0.08
Tax Burden
 1.00 1.00 4.30 1.33 1.01
Interest Burden
 2.15 4.04 7.33 4.69 2.48
Research & Development to Revenue
 0.00 0.00 0.00 0.02 0.03
SG&A to Revenue
 0.90 0.49 8.63 0.29 0.36
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 <0.01 <0.01
Income Quality
 0.32 0.17 -0.40 -0.67 0.91
Currency in CNY